Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid

A Martinetti1, E Seregni, E Bajetta

  • 1Nuclear Medicine Division, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.

The International Journal of Biological Markers
|July 1, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

ESMO open·2025
Same author

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109).

ESMO open·2025
Same author

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.

ESMO open·2022
Same author

The effect of tracheostomy on swallowing function in open partial horizontal laryngectomies: preliminary experience.

The Journal of laryngology and otology·2021
Same author

Sentinel node biopsy versus elective neck dissection in early-stage oral cancer: a systematic review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2020

A new method accurately measures estrogen levels (estradiol, estrone, estrone sulfate) in breast cancer patients undergoing endocrine therapy. This aids in assessing treatment effectiveness by quantifying residual hormones with high sensitivity.

Area of Science:

  • Endocrinology
  • Oncology
  • Analytical Chemistry

Background:

  • Endocrine therapy for breast cancer aims to inhibit estrogen's proliferative effect on neoplastic cells.
  • Aromatase inhibitors lower circulating estradiol (E2), estrone (E1), and estrone sulfate (E1-S) by blocking synthesis.
  • Measuring these hormones can indicate therapy efficacy, but current methods are challenging.

Purpose of the Study:

  • To develop a novel, sensitive, and efficient method for measuring plasma E2, E1, and E1-S levels.
  • To provide a reliable indicator for assessing the biological efficacy of endocrine therapy in breast cancer patients.

Main Methods:

  • A novel extraction method involving solid-phase extraction was developed.
  • The extracted samples were analyzed using a highly specific radioimmunoassay.

Related Experiment Videos

  • The method was validated for sensitivity in measuring E2, E1, and E1-S.

    • Main Results:

    • The novel method demonstrated high sensitivity for E2 (0.6 pg/ml), E1 (2.0 pg/ml), and E1-S (7.0 pg/ml).
    • This allows for the measurement of residual hormone levels previously difficult to quantify.
    • The method offers a more practical approach for evaluating therapy efficacy in large patient cohorts.

    Conclusions:

    • The described solid-phase extraction followed by radioimmunoassay is a sensitive and specific method for quantifying plasma E2, E1, and E1-S.
    • This technique can serve as a valuable tool for monitoring endocrine therapy response in breast cancer.
    • Improved measurement of hormone levels can lead to better patient management and treatment optimization.